In a statement, the Ministry of Defense stated that it approved clinical trials in humans of a vaccine against the new coronavirus developed by the Military Academy of Sciences.
The vaccine was developed by the team led by epidemiologist Chen Wei.
Several Chinese institutions today announced the launch of clinical trials in April to test the effectiveness of various virus vaccines.
According to the Ministry of Education, a vaccine based on influenza vectors is being developed that is currently being tested on animals and whose clinical trials will start in April with the participation of universities in Beijing, Tsinghua and Xiamen as well as other research institutions, According to the Xinhua State News Agency.
On the other hand, Deputy Director of the Shanghai City Health Commission, Yi Chengdong, said that Chinese scientists developed a vaccine using the genetic platform called mRNA (messenger RNA), which will enter clinical trials also in April.
Yi said it was developed based on viral proteins derived from the structural proteins of a virus.
However, three new products used in diagnostic tests to detect the new coronavirus were clinically approved and applied in Shanghai, said today Zhang Quan, director of the city's science and technology commission.
Up to now, at least three.326 people have died from Covid-19 in China among the 80.881 contagions recorded since the outbreak.
The outbreak began in China in December and spread over 146 countries and territories, which led the World Health Organization to declare a pandemic situation.
The coronavirus responsible for Covid-19's pandemic infected more than 189 thousand people, more than 7.800 dead.
From infected people around the world, over eight thousand have recovered from the disease.
The countries most affected after China are Italy, with two.503 deaths to 3.506 cases, Iran, with 988 deaths (16.169 cases), Spain, with 491 deaths (11.178 cases) and France with 148 deaths (6.633 cases)